Ascendis Pharma A/SASNDNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank38
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-219.03M
↑ 27% vs avg
Percentile
P38
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-300.48M
Historical baseline
PeriodValueYoY Change
2025$-219.03M+42.1%
2024$-378.08M+21.5%
2023$-481.45M+17.4%
2022$-583.19M-52.0%
2021$-383.58M+8.4%
2020$-418.95M-92.2%
2019$-218.02M-67.6%
2018$-130.10M-5.0%
2017$-123.90M-80.9%
2016$-68.50M-